Healthcare / Healthcare Payers • Healthcare Providers
Digital Therapeutics - Ophthalmology
What is Digital Therapeutics - Ophthalmology?
Companies in this market develop digital therapeutics to treat various ophthalmological conditions, such as amblyopia, myopia, and visual impairments from brain injuries. Many of them are developing video games — accessed through mobile apps or virtual reality headsets — that help improve visual acuity.
Selling a product or service?
Reach more buyers.
Your future customers are researching their next tech solution on CB Insights. Make sure they can find you.
Claim your CB Insights ProfileLeaders
Leaders are the most established service providers in the market and possess the breadth to address various customer needs.
See why these companies made it as leaders for Digital Therapeutics - Ophthalmology. These companies include Tilak Healthcare and S-Alpha Therapeutics.
France / Founded Year: 2016
Tilak Healthcare specializes in digital healthcare and is dedicated to the development of medically-prescribed video games for the monitoring and follow-up of patients suffering from chronic diseases. The company's application targets ophthalmology with macular diseases, which affect a large number of patients in the aging populations of developed countries.
South Korea / Founded Year: 2019
S-Alpha Therapeutics is a digital therapeutics company with platform technologies that enable digital devices to treat different diseases. S-Alpha has a pipeline of products in the areas of ophthalmology, neuropsychiatry, cancer, and immunology.
Highfliers
Highfliers are the most innovative service providers in the market and possess the resources to address evolving customer needs.
See why these companies made it as highfliers for Digital Therapeutics - Ophthalmology. These companies include .
Outperformers
Outperformers are the most specialized service providers in the market and possess the expertise to address unique customer needs.
See why these companies made it as outperformers for Digital Therapeutics - Ophthalmology. These companies include Nunaps.
South Korea / Founded Year: 2017
Nunaps is a digital therapeutics company that develops Nunaps Vision, a VR software that treats visual impairment after brain injury.
Key People
DongHo Kang
Challengers
Challengers are the most promising service providers in the market and possess the agility to address emerging customer needs.
See why these companies made it as challengers for Digital Therapeutics - Ophthalmology. These companies include Luminopia.
United States / Founded Year: 2015
Luminopia uses virtual reality goggles to correct amblyopia or lazy eye. Its technology also holds the potential to provide a way to detect this condition, which can frequently go undiagnosed.
Key People
Dean Travers, Scott Xiao
What is Digital Therapeutics - Ophthalmology?
Companies in this market develop digital therapeutics to treat various ophthalmological conditions, such as amblyopia, myopia, and visual impairments from brain injuries. Many of them are developing video games — accessed through mobile apps or virtual reality headsets — that help improve visual acuity.
Selling a product or service?
Reach more buyers.
Your future customers are researching their next tech solution on CB Insights. Make sure they can find you.
Claim your CB Insights Profile